TherapeuticsMD reported $-1.18M in Operating Profit for its fiscal quarter ending in June of 2024.





Operating Profit Change Date
AbbVie USD 6.72B 1.99B Jun/2026
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Cipla INR 8.88B 2.74B Jun/2026
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD -9.02M 65.06M Mar/2026
CSL USD 2.64B 1.97B Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Novo Nordisk DKK 5.25B 54.37B Jun/2026
Pfizer USD 667M 4.32B Jun/2026
TherapeuticsMD USD -1.18M 40K Jun/2024